Correction to: Secukinumab Versus Adalimumab for Psoriatic Arthritis: Comparative Effectiveness up to 48 Weeks Using a Matching-Adjusted Indirect Comparison.

Authors

Peter Nash
Iain B McInnes
Philip Mease, Swedish Medical Center and University of Washington, Seattle, WA, USA.Follow
Howard Thom
Matthias Hunger
Andreas Karabis
Kunal Gandhi
Shephard Mpofu
Steffen M Jugl

Document Type

Article

Publication Date

6-1-2018

Publication Title

Rheumatol Ther

Abstract

Under Methods section, heading Analyses: Pairwise Comparisons, one of the probability value was published incorrectly in a sentence. The correct sentence should read as follows.

Clinical Institute

Orthopedics & Sports Medicine

Department

Rheumatology

Recommended Citation

Nash, Peter; McInnes, Iain B; Mease, Philip; Thom, Howard; Hunger, Matthias; Karabis, Andreas; Gandhi, Kunal; Mpofu, Shephard; and Jugl, Steffen M, "Correction to: Secukinumab Versus Adalimumab for Psoriatic Arthritis: Comparative Effectiveness up to 48 Weeks Using a Matching-Adjusted Indirect Comparison." (2018). Articles, Abstracts, and Reports. 273.
https://digitalcommons.providence.org/publications/273